Hard To Treat Diseases releases details of patent

By Elaine Rigoli

Tampa, Fla., May 9 - Hard To Treat Diseases, Inc. said its patent application relating to cancer is the second of two patent applications that the company filed, owns and controls.

In December, the company filed a provisional patent application for Methods and Compositions for Treatment of Cancer. This application provides a novel method for inhibition and prevention of cancer, to the diseases associated with such cancers and to the therapeutic treatment of diseases or disorders caused by such cancers, according to a news release.

This application became a utility patent application in December, the release said.

The patent applications are the result of testing conducted on Tubercin (T-5) and Specific Substance of Maruyama, the release said.

Hard To Treat Diseases is a pharmaceutical company based in Delray Beach, Fla.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.